Cargando…
Sympathetic nervous signaling dictates prostate cancer progression
Autores principales: | Sigorski, D., Iżycka-Świeszewska, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907162/ https://www.ncbi.nlm.nih.gov/pubmed/35264555 http://dx.doi.org/10.1038/s41420-022-00928-3 |
Ejemplares similares
-
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
por: Sigorski, Dawid, et al.
Publicado: (2020) -
Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors
por: Sigorski, Dawid, et al.
Publicado: (2021) -
Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread
por: Sigorski, Dawid, et al.
Publicado: (2022) -
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020) -
Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
por: Dwivedi, Shubham, et al.
Publicado: (2021)